Pharmafile Logo
Pharmafocus logo
Advanced Search

The renal cell carcinoma market: Votrient to challenge Sutent’s lead

November 25, 2010
Sales and Marketing GSK, GlaxoSmithKline, Pfizer, Sutent, Votrient, rcc, renal cell carcinoma

After decades of no new medicines emerging to treat renal cell carcinoma, no fewer than five new drugs were approved …

Feature
Dr Reddy's Hyderabad, India

GSK sells antibiotics assets to Dr Reddy’s

November 24, 2010
Manufacturing and Production, Sales and Marketing Antibiotics, Dr Reddy's, GSK

Dr. Reddy’s Laboratories has bought a US oral penicillin facility from GSK, along with the US marketing rights to the …

News

Varnish chemical migrates into medicine bottles, says study

November 24, 2010
Manufacturing and Production AAPS, HDPE, chemical migration, varnish

A chemical found in the varnish coating of pharmaceutical bottles has been show to migrate into the contents and be …

News

Brain cancer vaccine to move into phase III

November 24, 2010
Research and Development, Sales and Marketing Celldex, Pfizer, brain cancer, glioblastoma

Celldex will press ahead with large-scale trials of its vaccine treatment for brain cancer after encouraging phase II results. The …

News

NICE recommends Herceptin for gastric cancer, blocks high dose Glivec

November 24, 2010
Sales and Marketing Cancer, GIST, Glivec, HER2, Herceptin, NICE, gastric cancer

NICE has recommended Roche’s cancer drug Herceptin for patients with HER2 metastatic gastric cancer. NICE was initially minded not to …

News

Healthcare, politics and the NHS

November 24, 2010
Research and Development Academy of Medical Sciences, Les Roes, NHS, clinical trials, clinical trials governance, evidence-based medicine

I have just participated in a consultation by the Academy of Medical Sciences on the regulation and governance of clinical …

Feature

Pharma manufacturing news in brief

November 23, 2010
Manufacturing and Production Alpah Biologics, Alpha Biologics, Kemwell, Lonza, Phil Taylor, Roche

Facility updates from Roche, Alpha Biologics, Kemwell and Reinnervate, new contract services from Lonza and Patheon, plus a milestone in …

News
brinsmeadweb

Brinsmead to be life sciences adviser to government

November 23, 2010
Sales and Marketing Brinsmead, NHS, government, life sciences

Chris Brinsmead, chairman of AstraZeneca UK, has been made the government’s life sciences business adviser. He was appointed by universities …

News

Roche to develop diagnostic tools for Tarceva

November 23, 2010
Sales and Marketing Genzyme, NSCLC, Roche, Tarceva, diagnostic

Roche has obtained a worldwide sub-license from Genzyme to develop a diagnostic kit for the detection of specific mutations for …

News

Vytorin cuts heart problems in kidney patients

November 23, 2010
Sales and Marketing Merck, Vytorin, cardiovascular, simvastatin

Vytorin has been shown to reduce potentially heart problems in patients with chronic kidney disease (CKD) in a new study. …

News

Offshore outsourcing in Regulatory Affairs and Pharmacovigilance

November 22, 2010
Sales and Marketing Kinapse, White paper

Based on Kinapse’s direct experience, we explore the emerging environment for regulatory and pharmacovigilance offshore outsourcing within the biopharmaceutical industry …

Feature
White paper

A new generation of analogues for valuing strategy

November 22, 2010
Sales and Marketing Alex Blyth, MSI, forecasting, marketing, marketing strategy

Anyone who is involved in the planning of pharma marketing campaigns will know that the Holy Grail is trying to …

Feature
synovate_chris_king

Chris King joins Synovate Healthcare

November 22, 2010
Sales and Marketing Chris King, Synovate Healthcare, appointment, sales and marketing

Synovate has appointed Chris King head of its European Oncology Monitor within its specialist healthcare research division. He joins the …

Appointment
Age-related macular degeneration (Wet AMD)

Bayer’s challenger to Lucentis shows promise

November 22, 2010
Research and Development, Sales and Marketing Bayer, Lucentis, Novartis, Regeneron, Roche, VEGF Trap-Eye, age-related macular degeneration, avastin, wet AMD

Phase III data for a new age-related macular degeneration (wet AMD) treatment show it is as good as Lucentis, the …

News

J&J and Takeda issue recall for cancer drug Velcade

November 22, 2010
Manufacturing and Production J&J, JJ, Johnson & Johnson, Takeda Pharmaceuticals, Velcade, bortezomib, pharma manufacturing, product recalls

Johnson & Johnson has been affected by another product recall, on this occasion concerning the cancer drug Velcade (bortezomib) sold …

News

Daiichi-Sankyo cleared of rep misconduct

November 22, 2010
Medical Communications, Sales and Marketing ABPI, ABPI Code of Practice, Daiichi Sankyo, Daiichi-Sankyo, Olmetec, PMCPA, olmesartan, pharma sales representative

Daiichi-Sankyo has been cleared of any wrongdoing in relation to the ABPI Code after one of its representatives was accused …

News

Pfizer’s axitinib impresses in head-to-head trial with Nexavar

November 22, 2010
Research and Development, Sales and Marketing Kidney cancer, Nexavar, Pfizer, axitinib, mRCC, metastatic renal cell carcinoma

Pfizer’s axitinib has impressed in phase III trials assessing its efficacy as a second line treatment for renal cell carcinoma. …

News
Blog footer

Digital Pharma: E-Health and the European agenda

November 19, 2010
Medical Communications Digital Agenda, Digital Pharma blog, EC, European Commission, Neelie Kroes, digital patients, e-health, electronic patient records

The European Commission wants all European patients to be given secure online access to their medical records by 2015 and …

News

Pharma sector growth to improve in 2011

November 19, 2010
Sales and Marketing 2011, IMS, IMS Health, forecast, growth, pharma

2011 should be a better year for pharma as emerging markets and recovering economies will help growth, say analysts at …

News

Bayer set for 4,500 job cuts

November 19, 2010
Research and Development, Sales and Marketing Bayer, Cost cutting, emerging markets

Bayer has announced large scale job losses aimed at saving 800 million euro savings in the coming years.The cuts are …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026